🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial is to study the effect of targeting the gut mic...
Status
Unknown
Location
Oslo University Hospital - Rikshospitalet
Start Date
2016-03-11
Trial ID
NCT02637167
Treatments Being Tested
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a highly prevalent...
Status
Completed
Location
University of Michigan
Start Date
2018-02-13
Trial ID
NCT03219528
Treatments Being Tested
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal d...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2018-07-01
Trial ID
NCT03462966
Treatments Being Tested
For HIV-infected patients who have access to treatment, liver diseases are ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01654939
Treatments Being Tested
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Enc...
Status
Recruiting
Location
Sherief Abd-Elsalam
Start Date
2018-11-01
Trial ID
NCT04161053
Treatments Being Tested
The epidemic of overweight and obese patients presents a major challenge in...
Status
Unknown
Location
Bayhealth Medical Center- Dover Family Physicians and GI Consultants Office
Start Date
2021-01-01
Trial ID
NCT04674176
Treatments Being Tested
The purpose of this study is to determine if the administration of a poorly...
Status
Unknown
Location
Columbia University Medical Center - NYPH
Start Date
2012-03
Trial ID
NCT01603108
This investigational trial will be assessing the effect of rifaximin on pat...
Status
Completed
Location
Copenhagen University hospital Hvidovre
Start Date
2012-11
Trial ID
NCT01769040
This study evaluates hepatic encephalopathy (HE) and liver-related hospital...
Status
Completed
Location
Queen Elizabeth Hospital
Start Date
2015-06
Trial ID
NCT02488993
Treatments Being Tested
Rifaximin is an antibiotic that acts locally in the gastrointestinal tract ...
Status
Terminated
Location
Sapienza University of Rome - Policlinico Umberto I Roma
Start Date
2021-04-03
Trial ID
NCT06630572